FdaApplication
BLA 761174
Identifiers
- fda_app_no: BLA761174
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2021-04-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JEMPERLI | DOSTARLIMAB-GXLY | 500MG/10ML (50MG/ML) | Injection |
1 product